I noticed here: https://pace-cme.org/2017/08/28/grand-debate-inflammation-and-cardiovascular-disease/

that, "Canakinumab is well-known to give mild reduction in white blood cells. Any infection was not statistically significantly increased, but fatal infections were"

I cannot recall off the top what effect, if any, RVX-208/apabetalone had on white blood cells. Anyone recall mention of that? 

I should add that the discussion went on to conclude that this was something that could be managed. Still wondered, though.